Healthcare
Polyrizon Achieves Key Manufacturing Milestone for Its Intranasal Allergy Protection Platform
Successful scale-up of PL-14 production paves the way for 2026 clinical trials and future commercial readiness. Polyrizon (PLRZ), a biotechnology...
A Breakthrough in Knee Osteoarthritis: Enlivex Reports Promising Six-Month Results for Allocetra
Sustained pain reduction, improved mobility, and strong safety profile position Allocetra™ as a potential game-changer for aging patients Enlivex Therapeutics...
Eli Lilly and Novo Nordisk Strike Weight-Loss Drug Deal with Trump Administration
Landmark agreement cuts drug prices, expands Medicare access, and grants tariff relief to leading obesity drugmakers Eli Lilly & Co....
Pfizer, Novo Nordisk Eye Metsera; Sarepta Sinks, Hertz Surges
Tuesday’s trading session saw major pharmaceutical deals, biotech setbacks, and a surprise comeback in the car rental sector. On Tuesday’s...
Kimberly-Clark and Kenvue Unite to Form Consumer Health Giant
Kimberly-Clark, the maker of household staples like Kleenex and Huggies, has announced plans to acquire Tylenol producer Kenvue in a...
Intensity Therapeutics Publishes Promising Phase 1/2 Results for Novel Cancer Drug INT230-6
Study in eBioMedicine shows strong disease control and survival benefits across multiple tumor types with minimal toxicity Intensity Therapeutics (INTS),...
Purple Biotech Reaches Key Manufacturing Milestone for Groundbreaking Tri-Specific Antibody IM1240
Achievement validates CAPTN-3 platform scalability and advances IM1240 toward first-in-human clinical trials in 2026 Purple Biotech (PPBT), a clinical-stage biotechnology...
Co-Diagnostics Expands Global Reach with New Saudi Joint Venture
CoMira Diagnostics to Localize PCR Manufacturing and Healthcare Innovation Across KSA and 18 MENA Countries Co-Diagnostics (CODX), a leading molecular...
Datavault AI and Wellgistics Partner to Revolutionize Prescription Tracking with Blockchain Technology
Collaboration aims to enhance transparency, efficiency, and patient safety through smart contract integration Datavault AI (DVLT), a leader in AI-powered...
Scienture Launches Commercial Sales of Arbli™, the First FDA-Approved Ready-to-Use Losartan Suspension
$256 million U.S. market opportunity drives expansion as company kicks off multi-channel promotional campaign Scienture Holdings (SCNX) announced the official...
